“…In 2001, it was reported for the first time that injection of HMGB1 around the sciatic nerve induced mechanical allodynia in rats [ 90 ]. Recently, increasing evidence has unveiled the pro-nociceptive role of HMGB1 in the peripheral tissue and spinal cord [ 16 , 18 , 29 , 80 , 89 ], and demonstrated that endogenous HMGB1 is involved in the pathogenesis of various types of intractable pain [ 11 , 15 ], including inflammatory pain [ 28 , 29 , 80 ], visceral pain [ 19 , 20 , 30 , 32 ], neuropathic pain [ 23 , 31 , 76 , 91 , 92 ], cancer pain [ 33 ], and post-stroke pain [ 34 ]. Endogenous HMGB1 also appears to play a key role in the development of CIPN in rats or mice treated with cancer chemotherapeutics, such as paclitaxel, oxaliplatin, and vincristine, considering the complete prevention of CIPN by inactivation of HMGB1 with HMGB1-nAb or TMα ( Figure 2 and Table 1) [ 8 , 9 , 10 , 11 ].…”